Home | Contact | Case Studies | News | Events | Downloads | Work With Us | European Funding  

Screening for Bioactivities in a Pharmaceutical Waste Stream

The Company

A pharmaceutical company which produces a treatment for venous insufficiency by extracting aescins from horse chestnuts.

Added Value From Waste:

The production process results in large amounts of “waste” horse chestnuts

Evaluation of the potential for conversion of the waste stream into an additional product stream was sought by the company

Solution Through ARE Research:

The “waste” material from the process has been subjected to a number of extraction processes to extract novel bioactives.

These extracts have been screened on a number of the bioactivity screening platforms available at Shannon ABC with encouraging results.

The lead extracts are currently undergoing further development at the centre.